Skip to content
Clinical Trials – home
DenmarkBack to Denmark

Clinical trials in Gandrup – page 3

404 clinical trials in Gandrup, Denmark across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

DenmarkOur site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)
Gandrup at a glance
404
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

404 trials in Gandrup

Open in trial search

Zenagamtide versus semaglutide: a study of blood sugar and weight reduction in adults with type 2 diabetes inadequately controlled on metformin and/or SGLT2 inhibitor

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Novo Nordisk A/S

HIV infection

Recruiting

Durable HIV-1 control with 10-1074-LS, 3BNC117-LS and nivolumab in adults on ART: a randomized double‑blind placebo‑controlled trial

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:Nivolumab
  • Sponsor:Aarhus University Hospital

Study on the Safety and Effectiveness of AZD0486 Alone or with Other Drugs for Adults with Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma, or Large B-Cell Lymphoma

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Acalabrutinib
  • Sponsor:AstraZeneca AB

Efficacy and Safety of Trontinemab with [18F]MK-6240 in Cognitively Unimpaired Individuals at Risk for Alzheimer’s Disease

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Florquinitau (18F)
  • Sponsor:F. Hoffmann-La Roche AG

Study of AZD6234 (lenbelintide) Added to Incretin Therapy in Adults with Obesity or Overweight and a Weight‑Related Comorbidity, With or Without Type 2 Diabetes

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:AZD6234
  • Sponsor:AstraZeneca AB

Phase 2 study of MK-7262 and enlicitide decanoate in adults with high lipoprotein(a)

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Enlicitide decanoate
  • Sponsor:Merck Sharp & Dohme LLC

Randomized trial of elecoglipron with dapagliflozin versus placebo in adults with type 2 diabetes mellitus and impaired renal function

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:AZD5004
  • Sponsor:AstraZeneca AB

Study of AZD0486 plus rituximab versus standard chemotherapy drug combination in previously untreated follicular lymphoma patients

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Cyclophosphamide
  • Sponsor:AstraZeneca AB

A Phase III Study of Elafibranor in Adults with Primary Sclerosing Cholangitis to Assess Efficacy and Safety

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Elafibranor
  • Sponsor:Ipsen Bioscience Inc.

Study of precemtabart tocentecan alone or in drug combination versus standard therapy in previously treated metastatic colorectal cancer patients

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Merck Healthcare KGaA

Efficacy and safety of lunsekimig in adults with inadequately controlled eosinophilic COPD: a randomized, double‑blind, placebo‑controlled trial

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Lunsekimig
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Rinatabart Sesutecan plus bevacizumab vs standard care as maintenance for recurrent platinum‑sensitive ovarian cancer after second‑line chemotherapy

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Genmab A/S

Other cities in Denmark

The busiest research cities in the country

All 45 cities in Denmark

Clinical research in Gandrup

What the registry says about research in the country

01 Musculoskeletal Disorders

Extensive research focusing on knee osteoarthritis treatments, including innovative pain management solutions and cartilage regeneration therapies. Multiple trials are evaluating new medications and therapeutic approaches.

  • Knee Pain Management
  • Cartilage Regeneration
  • Joint Function Improvement

Studies include novel treatments like diclofenac gel and experimental compounds for pain relief and joint health.

02 Metabolic Conditions

Innovative trials addressing obesity and type 2 diabetes, with a focus on weight management therapies combined with lifestyle modifications.

  • Weight Management
  • Diabetes Control
  • Metabolic Health

Research includes dual-approach treatments targeting both weight loss and diabetic control in patients with combined conditions.

03 Cardiovascular Research

Groundbreaking studies in atherosclerotic cardiovascular disease prevention and treatment, focusing on reducing major adverse cardiovascular events.

  • Heart Disease Prevention
  • Cardiovascular Risk Management
  • Lipid Disorders

Clinical trials are evaluating new medications for preventing cardiac events in high-risk populations.

04 Neurological Conditions

Important research into Alzheimer's disease and migraine treatments, including pediatric studies for headache prevention.

  • Early Alzheimer's Intervention
  • Migraine Prevention
  • Pediatric Neurology

Trials include innovative treatments for early-stage Alzheimer's and specialized migraine therapies for young patients.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.